Galapagos NV
GLPG27.7300.00% ( 0.000 )
Galapagos NV (GLPG)
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 27.730
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 37.780
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Galapagos NV Analyst Rating
View MoreForecast & Rating
Apr 7, 2026Price forecast
$28.011.00%
Forecast & RatingHold
3analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Apr 29 at 08:38 AM
Galapagos Shareholders Approve Name Change to Lakefront Biotherapeutics and Broad Governance Overhaul
- Market Beat · Apr 29 at 12:07 AM
Galapagos (GLPG) Expected to Announce Quarterly Earnings on Wednesday
- Unusual Whales · Apr 28 at 03:03 PM
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
- Market Beat · Apr 17 at 08:46 PM
Short Interest in Galapagos NV (NASDAQ:GLPG) Expands By 20.4%
- Market Beat · Apr 8 at 03:37 AM
Galapagos (NASDAQ:GLPG) Stock Crosses Below 200 Day Moving Average - Time to Sell?
- Tip Ranks · Mar 31 at 08:01 AM
Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves
